STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Avalo Therapeutics, Inc.

Filed

January 5, 2026

Period of Report

December 31, 2025

Accession Number

0001470831-26-000006